New strategies in photodynamic diagnosis of bladder cancer

Medical Laser Application

Volumn 18, Issue 1, 2003, Pages 41-46

  Durek, Christoph ^a   Jocham, Dieter ^a  

^a UNIVERSITY OF LÜBECK   (Germany)

Author keywords

Bladder carcinoma; Clinical study; Fluorescence cystoscopy; Hexyl 5 aminolevulinate hydrochloride

Indexed keywords

DRUG THERAPY; FLUORESCENCE; TUMORS;

WHITE LIGHT CYSTOSCOPY;

PHOTODYNAMIC THERAPY;

AMINOLEVULINIC ACID; AMINOLEVULINIC ACID HEXYL ESTER; PHOTOSENSITIZING AGENT; PROTOPORPHYRIN; UNCLASSIFIED DRUG;

BLADDER CARCINOMA; CANCER LOCALIZATION; CANCER SCREENING; CLINICAL TRIAL; CYSTOSCOPY; DIAGNOSTIC ACCURACY; EARLY DIAGNOSIS; FLUORESCENCE; HUMAN; PHOTODYNAMICS; REVIEW;

EID: 0037396085     PISSN: 16151615     EISSN: None     Source Type: Journal    
DOI: 10.1078/1615-1615-00086     Document Type: Review

References (19)

1. BRAUERS A, BUETTNER R, JAKSE G: Second resection and prognosis of primary high risk superficial bladder cancer: is cystectomy often too early? J Urol 165: 808-810 (2001)
2. BRUNNER H, HAUSMANN F, KRIEG RC, ENDLICHER E, SCHOLMERICH J, KNUECHEL R, MESSMANN H: The effects of 5-aminolevulinic acid esters on protoporphyrin IX production in human adenocarcinoma cell lines. Photochem Photobiol 74: 721-725 (2001)
3. D'HALLEWIN MA, BAERT L, VANHERZEELE H: In vivo fluorescence detection of human bladder carcinoma without sensitizing agents. J Am Paraplegia Soc 17: 161-164 (1994)
4. D'HALLEWlN MA, KAMUHABWA AA, ROSKAMS T, DE WITTE PA, BAERT L: Hypericin-based fluorescence diagnosis of bladder carcinoma. BJU Int 89: 760-763 (2002)
5. FILBECK T, PICHLMEIER U, KNUECHEL R, WIELAND WF, ROESSLER W: Clinically relevant improvement of recurrencefree survival with 5-aminolevulinic acid induced fluorescence diagnosis in patients with superficial bladder tumors. J Urol 168: 67-71 (2002)
6. FILBECK T, PICHLMEIER U, KNUECHEL R, WIELAND WF, ROESSLER W: Do patients profit from 5-aminolevulinic acidinduced fluorescence diagnosis in transurethral resection of bladder carcinoma? Urology 60: 1025-1028 (2002)
7. FUKUI I, YOKOKAWA M, MITANI G, OHWADA F, WAKUI M, WASHIZUKA M, TOHMA T, IGARASHI K, YAMADA T: In vivo staining test with methylene blue for bladder cancer. J Urol 130: 252-255 (1983)
8. HENEY NM, NOCKS BN, DALY JJ, G.R.PROUT JR., NEWALL IB, GRIFFIN PP, PERRONE TL, SZYTELBEIN W: Ta and T1 bladder cancer: location, recurrence and progression. Br J Urol 54: 152-157 (1982)
9. HERR W: The value of a second transurethral resection in evaluating patients with bladder tumors. J Urol 162: 74-76 (1999)
10. JOCHAM D, BAUMGARTNER R, FUCHS N, LENZ H, STEPP H, UNSOELD E: Fluorescence diagnosis of porphyrin-marked urothelial tumors. Status of experimental development. Urologe A 28: 59-64 (1989)
11. KRIEGMAIR M, BAUMGARTNER R, KNUECHEL R, STEINBACH P, EHSAN A, LUMPER W, HOFSTAEDTER F, HOFSTETTER A: Fluorescence photodetection of neoplastic urothelial lesions following intravesical instillation of 5-aminolevulinic acid. Urology 44: 836-841 (1994)
12. KRIEGMAIR M, ZAAK D, ROTHENBERGER KH, RASSWEILER J, JOCHAM D, EISENBERGER F, TAUBER R, STENZL A, HOFSTETTER A: Transurethral resection for bladder cancer using 5-aminolevulinic acid induced fluorescence endoscopy versus white light endoscopy. J Urol 168: 475-478 (2002)
13. LANGE N, JICHLINSKI P, ZELLWEGER M, FORRER M, MARTI A, GUILLOU L, KUCERA P, WAGNIERES G, VAN DEN BERGH H: Photodetection of early human bladder cancer based on the fluorescence of 5-aminolaevulinic acid hexylester-induced protoporphyrin IX: a pilot study. Br J Cancer 80: 185-193 (1999)
14. MARTI A, LANGE N, SEDMERA D, JICHLINSKI P, KUCERA P: Optimisation of the formation and distribution of protoporphyrin IX in the urothelium: an in vitro approach. J Urol 162: 546-552 (1999)
15. UTZ DC, FARROW GH, RIFE CC, SEGURA JW, ZINCKE M: Carcinoma in situ of the bladder. Cancer 45: 1842-1848 (1980)
16. VAN DER MEIJDEN A, OOSTERLINCK W, BRAUSI M, KURTH KH, SYLVESTER R, DE BALINCOURT C: Significance of bladdei biopsies in Ta, T1 bladder tumors: a report from the EORTC Genito-Urinary Tract Cancer Cooperative Group. EORTCGU Group Superficial. Eur Urol 35: 267-271 (1999)
17. WHITMORE WF JR, BUSH IM: Ultraviolet cystoscopy in patients with bladder cancer. Trans Am Assoc Genitourin Surg 57: 149-155 (1965)
18. ZAAK D, KRIEGMAIR M, STEPP H, BAUMGARTNER R, OBERNEDER R, SCHNEEDE P, CORVIN S, FRIMBERGER D, KNUECHEL R, HOFSTETTER A: Endoscopic detection of transitional cell carcinoma with 5-aminolevulinic acid: results of 1012 fluorescence endoscopies. Urology 57: 690-694 (2001)
19. ZEIN T, WAJSMAN Z, ENGLANDER LS, GAMARRA M, LOPEZ C, HUBEN RP, PONTES JE: Evaluation of bladder washings and urine cytology in the diagnosis of bladder cancer and its correlation with selected biopsies of the bladder mucosa. J Urol 132: 670-671 (1984)